{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:57:03Z","timestamp":1754485023038},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.cyto.2016.11.016","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T19:31:45Z","timestamp":1481225505000},"page":"6-9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Serological signatures of clinical cure following successful treatment with sodium stibogluconate in Ethiopian visceral leishmaniasis"],"prefix":"10.1016","volume":"91","author":[{"given":"Endalamaw","family":"Gadisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geremew","family":"Tasew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adugna","family":"Abera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woyneshet","family":"Gelaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menberework","family":"Chanyalew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markos","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Laskay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.11.016_b0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/381203","article-title":"Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan","volume":"38","author":"Collin","year":"2004","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.cyto.2016.11.016_b0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4269\/ajtmh.2009.81.373","article-title":"Natural history of a visceral leishmaniasis outbreak in highland Ethiopia","volume":"81","author":"Herrero","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cyto.2016.11.016_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","article-title":"Visceral leishmaniasis and HIV in Tigray, Ethiopia","volume":"8","author":"Lyons","year":"2003","journal-title":"Trop. Med. Int. Health: TM & IH"},{"key":"10.1016\/j.cyto.2016.11.016_b0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4314\/eamj.v83i7.9451","article-title":"Visceral leishmaniasis in northern Ethiopia","volume":"83","author":"Haile","year":"2006","journal-title":"East Afr. Med. J."},{"key":"10.1016\/j.cyto.2016.11.016_b0025","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2016.11.016_b0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.trstmh.2007.06.001","article-title":"Visceral leishmaniasis in eastern Africa \u2013 current status","volume":"101","author":"Reithinger","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cyto.2016.11.016_b0035","unstructured":"WHO, Visceral Leishmaniasis: Control Strategies and Epidemiological Situation Update in East Africa, Report of a WHO Bi-regional Consultation, Addis Ababa, Ethiopia, 9\u201311 March 2015, WHO Library Cataloguing-in-Publication Data, World Health Organization, Geneva, 2015."},{"key":"10.1016\/j.cyto.2016.11.016_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajpath.2011.03.009","article-title":"Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasis","volume":"179","author":"Yurdakul","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2016.11.016_b0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2334-13-331","article-title":"High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis","volume":"13","author":"de Oliveira","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2016.11.016_b0050","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.4049\/jimmunol.164.11.5858","article-title":"IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40\/CD40 ligand-dependent process","volume":"164","author":"Marovich","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.016_b0055","doi-asserted-by":"crossref","first-page":"e0141265","DOI":"10.1371\/journal.pone.0141265","article-title":"Soluble CD40 ligand in sera of subjects exposed to leishmania infantum infection reduces the parasite load in macrophages","volume":"10","author":"Oliveira","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2016.11.016_b0060","doi-asserted-by":"crossref","first-page":"e10107","DOI":"10.1371\/journal.pone.0010107","article-title":"Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis","volume":"5","author":"Verma","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2016.11.016_b0065","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10096-013-1999-1","article-title":"Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment","volume":"33","author":"Duthie","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis.: Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"10.1016\/j.cyto.2016.11.016_b0070","unstructured":"FMoH, in: N. Unit (Ed.), Guideline for Diagnosis, Treatment and Prevention of Leishmaniasis in Ethiopia, second ed., Ethiopian Federal Ministry of Health, Addis Ababa; 2013."},{"key":"10.1016\/j.cyto.2016.11.016_b0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13071-015-0987-y","article-title":"Eco-epidemiology of visceral leishmaniasis in Ethiopia","volume":"8","author":"Gadisa","year":"2015","journal-title":"Paras. Vect."},{"key":"10.1016\/j.cyto.2016.11.016_b0080","doi-asserted-by":"crossref","first-page":"e0003556","DOI":"10.1371\/journal.pntd.0003556","article-title":"Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging","volume":"9","author":"Reimao","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cyto.2016.11.016_b0085","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jac\/dkr185","article-title":"Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis","volume":"66","author":"Sudarshan","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cyto.2016.11.016_b0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1024\/0300-9831.75.4.257","article-title":"The expression of matrix metalloproteinases 8 and 9 by neutrophils of Wistar albino rats with severe qualitative and quantitative protein malnutrition","volume":"75","author":"Kozaci","year":"2005","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"10.1016\/j.cyto.2016.11.016_b0095","doi-asserted-by":"crossref","first-page":"e0141265","DOI":"10.1371\/journal.pone.0141265","article-title":"Soluble CD40 ligand in sera of subjects exposed to Leishmania infantum infection reduces the parasite load in macrophages","volume":"10","author":"de Oliveira","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2016.11.016_b0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-5-113","article-title":"Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis","volume":"5","author":"Caldas","year":"2005","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2016.11.016_b0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/S1413-86702009000100010","article-title":"Increased levels of IL-10, IL-12, and IFN- in patients with visceral leishmaniasis","volume":"13","author":"Khoshdel","year":"2009","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.11.016_b0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CDLI.11.4.635-641.2004","article-title":"Targeting CD40L: a promising therapeutic approach","volume":"11","author":"Daoussis","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616305890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616305890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T16:58:12Z","timestamp":1601225892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616305890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":22,"alternative-id":["S1043466616305890"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.11.016","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serological signatures of clinical cure following successful treatment with sodium stibogluconate in Ethiopian visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}